BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37661916)

  • 1. Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells.
    Shan X; Gegentuya ; Wang J; Feng H; Zhang Z; Zheng Q; Zhang Q; Yang K; Wang J; Xu L
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C1058-C1072. PubMed ID: 37661916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
    Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
    Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axis.
    Jiang Q; Lu W; Yang K; Hadadi C; Fu X; Chen Y; Yun X; Zhang J; Li M; Xu L; Tang H; Yuan JX; Wang J; Sun D
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C136-49. PubMed ID: 27194472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs.
    Zhang J; Lu W; Chen Y; Jiang Q; Yang K; Li M; Wang Z; Duan X; Xu L; Tang H; Sun D; Wang J
    Am J Physiol Cell Physiol; 2016 Sep; 311(3):C482-97. PubMed ID: 27413173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
    Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
    Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMYD2-Methylated PPARγ Facilitates Hypoxia-Induced Pulmonary Hypertension by Activating Mitophagy.
    Li Y; Wei X; Xiao R; Chen Y; Xiong T; Fang ZM; Huo B; Guo X; Luo H; Wu X; Liu L; Zhu XH; Hu Q; Jiang DS; Yi X
    Circ Res; 2024 Jun; 135(1):93-109. PubMed ID: 38770649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostanoid EP
    Li HH; Hsu HH; Chang GJ; Chen IC; Ho WJ; Hsu PC; Chen WJ; Pang JS; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L349-L359. PubMed ID: 29146573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
    Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
    Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
    Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
    Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF; Liu XR; Yang N; Lin MJ
    Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells.
    Dong F; Zhang J; Zhu S; Lan T; Yang J; Li L
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):426-435. PubMed ID: 31725079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
    Paffett ML; Lucas SN; Campen MJ
    Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
    Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
    Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin S promotes the development of pulmonary arterial hypertension.
    Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1-targeted and -dependent mechanism in PASMCs.
    Yang K; Zhao M; Huang J; Zhang C; Zheng Q; Chen Y; Jiang H; Lu W; Wang J
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C428-C438. PubMed ID: 29351409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis.
    Wang J; Yang K; Xu L; Zhang Y; Lai N; Jiang H; Zhang Y; Zhong N; Ran P; Lu W
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):231-40. PubMed ID: 23526219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.